MyAverix Finance
SHG · Healthcare
Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336)
Biotechnology
Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $44.21B, P/E ratio is 51.09, net margin is 70.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336) — FAQ
What is Sunshine Guojian Pharmaceutical Shanghai Co Ltd's market cap?
Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336) has a reported market cap of $44.21B (data as of 2026-03-29).
What is 688336's P/E ratio?
The price-to-earnings (P/E) ratio for Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336) is 51.09 (data as of 2026-03-29).
Does Sunshine Guojian Pharmaceutical Shanghai Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336). Check the MyAverix Finance app for the latest dividend data.
What sector is Sunshine Guojian Pharmaceutical Shanghai Co Ltd in?
Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688336 listed on?
688336 is listed on SHG.
What is Sunshine Guojian Pharmaceutical Shanghai Co Ltd's net margin?
Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336) reports a net margin of 70.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.